Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-2952 in female subjects with IBS-D
NCT01844180Phase 2Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Apr 2013
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ONO-2952 in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by Ono Pharmaceutical. Started Apr 2013; status: completed.
02
Drugs
ONO-2952
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT01844180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01844180.